ArticleCancers2021

Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk.

Soong June Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.